Stem Financial Statements From 2010 to 2024
| STMH Stock | USD 0.01 0.00 0.00% |
Check Stem Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Stem Holdings' main balance sheet or income statement drivers, such as , as well as many indicators such as . Stem financial statements analysis is a perfect complement when working with Stem Holdings Valuation or Volatility modules.
Stem |
Stem Holdings OTC Stock Return On Equity Analysis
Stem Holdings' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Stem Holdings Return On Equity | -0.65 |
Most of Stem Holdings' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Stem Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Stem Holdings has a Return On Equity of -0.6482. This is 97.3% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on equity for all United States stocks is 109.1% higher than that of the company.
Stem Holdings Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Stem Holdings's current stock value. Our valuation model uses many indicators to compare Stem Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Stem Holdings competition to find correlations between indicators driving Stem Holdings's intrinsic value. More Info.Stem Holdings is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Stem Holdings by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Stem Holdings' OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Stem Holdings Financial Statements
Investors use fundamental indicators, such as Stem Holdings' revenue or net income, to determine how well the company is positioned to perform in the future. Although Stem Holdings' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Stem Holdings, Inc. operates as a vertically-integrated cannabis products and technology company. The company was incorporated in 2016 and is headquartered in Boca Raton, Florida. Stem Holdings operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 450 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Stem OTC Stock
Stem Holdings financial ratios help investors to determine whether Stem OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Stem with respect to the benefits of owning Stem Holdings security.